Technical analysis of Evogene Ltd. (EVGN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform.
Price Performance
| 1 month | -14.90% |
| 3 months | -5.58% |
| Year-to-date | -54.93% |
| 1 year | -59.02% |
| 3 years | -92.62% |
| 5 years | -98.37% |
52-Week Range
| 52-week High | $1.50 |
| 52-week Low | $0.37 |
| Avg Volume (90d) | 1.4M |
Technical Indicators
| SMA 50 | $0.55 |
| SMA 200 | $0.77 |
| Beta | 0.95 |
| 30-day Volatility (annualised) | 89.5% |
| Price vs SMA 50 | -9.6% |
| Price vs SMA 200 | -35.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.26 | |
| 2025-11 | $1.06 | -15.9% |
| 2025-12 | $1.10 | +3.8% |
| 2026-01 | $1.01 | -8.2% |
| 2026-02 | $0.88 | -13.1% |
| 2026-03 | $0.77 | -12.3% |
| 2026-04 | $0.78 | +1.3% |
| 2026-05 | $0.70 | -9.6% |
| 2026-06 | $0.44 | -37.7% |
| 2026-07 | $0.47 | +7.3% |
| 2026-08 | $0.54 | +13.9% |
| 2026-09 | $0.50 | -7.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.50 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | IL |
Valuation Ratios
| Price / Book | -1.98 |
| EV / EBITDA | 0.19 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.64 |
| Current Ratio | 3.57 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -20.48 |